Medical devices, healthcare technology and the business of care
510(k) clearance · K254215

Arthrex Beaming System

ARTHREX, INC. · Decision date May 8, 2026

FDA DECISIONK254215

What did the FDA decide?

FDA records K254215 as a 510(k) premarket notification, with a decision dated May 8, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
May 8, 2026

FDA source record

Regulatory record facts

Identifier
K254215
Regulatory pathway
510(k) premarket notification
Applicant
ARTHREX, INC.
Product code
HWC
Decision code
SESE
Decision date
May 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Screw, Fixation, Bone.

Applicant
Arthrex, Inc.
Product code
HWC
FDA device class
2

FDA decision timeline

  1. K254215 received

    Application receipt date recorded by FDA.

  2. K254215 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HWC

Product / regulatory recordCompanyPathwayDecision dateSource
GM Dos Reis Industria e Comercio Ltda.510(k) clearanceNov 2, 2026FDA
Nvision Biomedical Technologies510(k) clearanceOct 14, 2026FDA
OsteoCentric Technologies510(k) clearanceOct 2, 2026FDA
ARTHREX, INC.510(k) clearanceSep 25, 2026FDA
MEDSHAPE, INC.510(k) clearanceSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arthrex, Inc.

Headquarters
Not reported
Brand website
arthrex.com
FDA applicant address
Naples, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records